May 12 (Reuters) - Jiangsu Hengrui Pharmaceuticals, China's biggest drugmaker by market value, on Tuesday said it struck ...

May 12 (Reuters) - China's Jiangsu Hengrui Pharmaceuticals said on Tuesday it has struck global collaboration and licensing ...

This may be an excellent deal for those focused on the long game.

The agreement covers 13 early-stage programs in oncology, hematology, and immunology, with $600 million due upfront ...

Bristol Myers Squibb and China's Hengrui Pharma are teaming up to advance more than a dozen early-stage drugs, in a deal ...

In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $58.96, denoting a +1.85% move from the preceding trading day.

TORONTO (AP) — There are 70-year-olds who want to be like June Squibb when they grow up. Squibb, 95, wasn’t the lead of a movie until she was 94. Now, a year after she turned action star in “Thelma,” ...

A woman holds test tube in front of displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration May 12 (Reuters) - Jiangsu Hengrui Pharmaceuticals, ...

The latest medicines from Bristol Myers Squibb (BMY 2.81%) were the driving force behind the company's considerable share ...